H6508
Heparin−Agarose
Type I, saline suspension
Synonym(s):
Heparin beads, Heparin resin
Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
About This Item
biological source
heparin from Porcine intestinal mucosa
Quality Level
type
Type I
form
saline suspension
extent of labeling
400-1500 μg per mL packed gel (activity approx. 140 USP units per mg)
technique(s)
affinity chromatography: suitable
matrix
cross-linked 4% beaded agarose
matrix activation
cyanogen bromide
matrix attachment
amino
matrix spacer
1 atom
suitability
suitable for chromatography
storage temp.
2-8°C
Application
Heparin-agarose is developed from porcine intestinal mucosa and is used in affinity chromatography. Heparin-agarose has been used in studies to provide information on human monocytic ehrlichiosis, tumor necrosis and the effects of coagulation from Vipera snake venom.
Physical form
Suspension in 0.5 M NaCl containing preservative
Still not finding the right product?
Explore all of our products under Heparin−Agarose
Storage Class
10 - Combustible liquids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Gloves, type N95 (US)
signalword
Warning
hcodes
Hazard Classifications
Skin Sens. 1
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Related Content
I V Kaplan et al.
Atherosclerosis, 158(2), 455-463 (2001-10-05)
Oxidation of beta-lipoproteins has been linked to the development of arteriosclerosis. Using a copper mediated cell free system to oxidize beta-lipoproteins, we found that beta -lipoproteins isolated from plasma were less susceptible to oxidation than lipoproteins from serum and that
D A Willins et al.
The Journal of biological chemistry, 266(17), 10768-10774 (1991-06-15)
Exogenous leucine affects the expression of a number of different operons in Escherichia coli. For at least some of these operons, the leucine-related effect is mediated by a protein called Lrp (Leucine-responsive regulatory protein). The purification of Lrp to near
M E Silvestri et al.
Scandinavian journal of immunology, 53(3), 282-289 (2001-03-17)
An investigation was performed into the heparin-binding properties of a synthetic peptide deduced from the sequence of human cytomegalovirus glycoprotein B. The peptide, T7-13:3, amino acids 69-78, which was previously shown to contain a neutralization epitope was able to bind
Global Trade Item Number
| SKU | GTIN |
|---|---|
| H6508-2.5ML | 04061836972042 |
| H6508-100ML | 04061833801062 |
| H6508-25ML | 04061837766039 |
| H6508-5ML | 04061833801116 |